期刊
MINERVA PEDIATRICS
卷 73, 期 6, 页码 474-485出版社
EDIZIONI MINERVA MEDICA
DOI: 10.23736/S2724-5276.21.06531-9
关键词
Pancreas artificial; Diabetes mellitus, type 1; Child
类别
Significant progress has been made in diabetes management technologies such as HCL and AHCL systems, which have shown to improve glucose control and quality of life in pediatric T1D patients. However, there are still limitations and challenges that need to be addressed through further research and improvements to facilitate their use in routine clinical practice.
Over the last years significant advances have been achieved in the development of technologies for diabetes management. Continuous subcutaneous insulin infusion (CSII), continuous glucose monitoring (CGM), predictive low glucose management (PLGM), hybrid closed loop (HCL) and advanced hybrid closed loop (AHCL) systems allow better diabetes management, thus reducing the burden of the disease and the risk of chronic complications. This review summarizes the main characteristics of the currently available HCL and AHCL systems and their primary effects in children and adolescents with type 1 diabetes (T1D). The findings of trials assessing the glucose control (time in range, HbA1c values, hypoglycemic events), the health-related quality of life and the existing limits of the use of these technologies are reported. The most recent data clearly confirm the ability of the HCL and AHCL insulin delivery systems to safely achieve a significant improvement of glucose control and quality of life in the pediatric population with T1D. Further studies are underway to overcame current barriers and future improvements in the usability of these technologies are awaited to facilitate their use in the routine clinical practice. The HCL and AHCL algorithms are the key features of today's insulin delivery systems that mark a crucial step towards fully automated closed loop systems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据